Русский 
English 
Deutsch 
Español 
العربية 
中文 
Türkçe 
Français 
Italiano 
What is Rheumatoid Arthritis of the Hand?
Rheumatoid Arthritis (RA) is a chronic autoimmune disease in which the immune system attacks the synovial membrane of joints. The hands and wrists are affected in 90% of RA patients, often symmetrically and in early stages.
Disease-modifying therapy (methotrexate, biologic agents) slows progression, but does not regenerate already destroyed joints. MIBRAR® complements disease-modifying therapy by restoring damaged tissues.
Symptoms:
- Morning stiffness lasting more than 30 minutes
- Swelling and tenderness of metacarpophalangeal joints (MCP)
- Symmetric involvement of both hands
- Deformities: ulnar deviation, swan neck, boutonniere
- Progressive loss of hand function
Characteristics of RA of the Hand:
- Pannus — abnormal tissue that destroys cartilage and bone
- Erosions — destruction of bone tissue
- Tenosynovitis — inflammation of tendons with risk of rupture
- Subluxations — instability of finger joints
Facts About RA of the Hand
- ICD-10: M05.8
- Prevalence: 0.5-1% of population
- Hands affected: in 90% of patients
- Gender: women 3 times more often
- Age: 30-60 years
How MIBRAR® Helps with Rheumatoid Arthritis
MIBRAR® does not replace disease-modifying therapy, but complements it — restoring what disease-modifying drugs cannot: regenerating damaged cartilage and reducing local inflammation in joints.
Assessment of Damage
MRI and ultrasound of the hands determine the degree of cartilage damage, presence of erosions, synovitis, and tenosynovitis. Disease activity is evaluated.
Obtaining Concentrates
CGF — anti-inflammatory factors. Lipogems® — mesenchymal stem cells with powerful immunomodulatory and regenerative action.
Injection into Joints
Under Sono Control Arm™ navigation, concentrates are injected into affected hand and wrist joints, into tendon sheaths. All joints are treated in a single procedure.
Immunomodulation and Regeneration
Stem cells modulate the immune response (reduce T-cell activity), suppress pannus, and initiate cartilage regeneration. Result — reduction in pain and swelling, improved hand function.
MIBRAR® Method Advantages
95% of interventions covered
MIBRAR® covers up to 95% of all spinal neurosurgery and orthopedic operations.
No anesthesia or incisions
Outpatient treatment via 0.3-1.5 mm puncture. No general anesthesia or hospitalization.
No age restrictions
Regeneration at any age. Safe for chronic conditions and anesthesia intolerance.
Rapid improvement
Concentrates have analgesic and anti-inflammatory properties. Relief within days.
Multiple zones at once
Simultaneous treatment of multiple discs or joints in one procedure.
Home the same day
No crutches, braces or rehabilitation needed. MRI follow-up at 8-16 weeks.
MIBRAR® Technology
Cyber Navi Hand™
Intraoperative robotic navigation system. Provides precise access to deep structures with 1 mm and 1 degree accuracy.
Sono Control Arm™
Device for intervention under sonographic control. Eliminates open surgeries with real-time visual monitoring.